Publication: Re: Alexander B.C.D. Ng, Aqua Asif, Ridhi Agarwal, et al. biparametric vs multiparametric MRI for prostate cancer diagnosis: the PRIME diagnostic clinical trial. JAMA 2025;334:1170–9
| dc.contributor.coauthor | Chen, Minghui | |
| dc.contributor.coauthor | D'Amico, Anthony Vincent | |
| dc.contributor.department | KUH (Koç University Hospital) | |
| dc.contributor.facultymember | No | |
| dc.contributor.kuauthor | Tilki, Derya | |
| dc.contributor.schoolcollegeinstitute | KUH (KOÇ UNIVERSITY HOSPITAL) | |
| dc.date.accessioned | 2026-01-16T08:47:00Z | |
| dc.date.available | 2026-01-16 | |
| dc.date.issued | 2025 | |
| dc.description.abstract | N/A | |
| dc.description.fulltext | No | |
| dc.description.harvestedfrom | Manual | |
| dc.description.indexedby | Scopus | |
| dc.description.indexedby | PubMed | |
| dc.description.openaccess | N/A | |
| dc.description.peerreviewstatus | Peer-Reviewed | |
| dc.description.publisherscope | International | |
| dc.description.readpublish | N/A | |
| dc.description.sponsoredbyTubitakEu | N/A | |
| dc.description.studentonlypublication | No | |
| dc.description.studentpublication | No | |
| dc.description.version | N/A | |
| dc.identifier.doi | 10.1016/j.eururo.2025.10.025 | |
| dc.identifier.embargo | No | |
| dc.identifier.issn | 0302-2838 | |
| dc.identifier.pubmed | 41390327 | |
| dc.identifier.quartile | N/A | |
| dc.identifier.scopus | 2-s2.0-105025127393 | |
| dc.identifier.uri | https://doi.org/10.1016/j.eururo.2025.10.025 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14288/32110 | |
| dc.keywords | N/A | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier b.v. | |
| dc.relation.affiliation | Koç University | |
| dc.relation.collection | Koç University Institutional Repository | |
| dc.relation.ispartof | European Urology | |
| dc.relation.openaccess | No | |
| dc.rights | Copyrighted | |
| dc.subject | Medicine | |
| dc.title | Re: Alexander B.C.D. Ng, Aqua Asif, Ridhi Agarwal, et al. biparametric vs multiparametric MRI for prostate cancer diagnosis: the PRIME diagnostic clinical trial. JAMA 2025;334:1170–9 | |
| dc.type | Letter | |
| dspace.entity.type | Publication | |
| relation.isOrgUnitOfPublication | f91d21f0-6b13-46ce-939a-db68e4c8d2ab | |
| relation.isOrgUnitOfPublication.latestForDiscovery | f91d21f0-6b13-46ce-939a-db68e4c8d2ab | |
| relation.isParentOrgUnitOfPublication | 055775c9-9efe-43ec-814f-f6d771fa6dee | |
| relation.isParentOrgUnitOfPublication.latestForDiscovery | 055775c9-9efe-43ec-814f-f6d771fa6dee |